GW Researcher Awarded $2.4M to Study the Role of the Brain in Obesity-Induced Hypertension

The five-year study will look at a possible link between stress in the brain and obesity-induced hypertension
Dr. Colin Young posing for a portrait

WASHINGTON (March 12, 2018) — Obesity is a problem that affects about 30 percent of the population in the United States. Many obese individuals are at risk of developing high blood pressure, or hypertension. This can lead to stroke, heart failure, and atherosclerosis. However, it is currently unclear what causes obesity-induced hypertension.

The National Institutes of Health recently awarded more than $2.4 million to a research team led by Colin Young, PhD, assistant professor of pharmacology and physiology at the George Washington University (GW) School of Medicine and Health Sciences, to study how cell stress in the brain could impact the risk of obesity-induced hypertension.

“We believe there are changes in the brain that occur when individuals become obese,” said Young. “We believe these changes alter how the brain communicates with, for example, the blood vessels and the kidneys, leading to the development of hypertension.”

Through this study, Young and his team want to understand what happens in the brain with obesity that might lead to alterations in stress-related and inflammation-related processes occurring within the cells that may lead to increased blood pressure. They hypothesize that when an individual becomes obese, it creates cell stress within the brain that can lead to low-grade inflammation in the brain. Young also explained that the team will look at the neurocircuitry in specific areas in the brain.

“We see that cardiovascular disease is the leading cause of death worldwide and we have 30 percent of the population that’s obese,” Young explained. “If we find that these potential pathways are impacted, it might lend insight into the potential use of already available drugs that aren’t used in hypertension or obesity, to determine if they could be good candidates for treatment.”

Young is working with co-investigator Anastas Popratiloff, MD, PhD, adjunct associate professor of anatomy and regenerative biology at the GW School of Medicine and Health Sciences, who also serves as director of the GW Nanofabrication and Imaging Center.

The study, titled “Forebrain Hypothalamic Mechanisms in Obesity-Induced Hypertension,” will be funded for five years.

Latest News

The George Washington University (GW) School of Medicine and Health Sciences (SMHS) MD Class of 2024 discovered where they will continue their training as physicians on Match Day, March 15, 2024.
Children’s National Hospital has appointed Nathan Kuppermann, MD, MPH, as its new executive vice president (EVP), chief academic officer (CAO) and chair of pediatrics.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) welcomed representatives from fellow Washington, D.C. area Upward Bound partners Howard University, Morgan State University, and the College Success Foundation, to celebrate the 38th annual National TRiO Day on Feb…